Home | MyCME | All CME | Blog | Psychlopedia
All Available CME Activities
Multimedia | CME From JCP | JCP Supplement | CME From PCC

MultimediaIn a series of brief video segments, experts in neurology, psychiatry, and primary care discuss the diagnosis and treatment of Alzheimer’s disease. [top]

A Multidisciplinary Approach for Addressing Challenges in Alzheimer’s Disease

A Multidisciplinary Approach for Addressing Challenges in Alzheimer’s Disease

Alireza Atri, MD, PhD; Simon Sheard, DO; and Danielle Goldfarb, MD

Cognitive Assessment of Alzheimer’s Disease and Dementias in Clinical Practice: Pragmatics of Brief Instruments and Neuropsychological Evaluation

Lynn Shaughnessy, PsyD; Simon Sheard, DO; Danielle Goldfarb, MD; and Alireza Atri, MD, PhD

Disclosure of Alzheimer’s Disease and Dementia: Patient- and Care Partner-Centric Decision-Making and Communication

Danielle Goldfarb, MD; Simon Sheard, DO; Lynn Shaughnessy, PsyD; and Alireza Atri, MD, PhD

New Mechanisms, New Opportunities: Integrating Novel Antidepressants in the Treatment of Major Depressive Disorder

New Mechanisms, New Opportunities: Integrating Novel Antidepressants in the Treatment of Major Depressive Disorder

Leslie Citrome, MD, MPH; James W. Murrough, MD, PhD; Joseph F. Goldberg, MD; Bradley N. Gaynes, MD, MPH; and Terence Ketter, MD

Managing Transitions in Care and Adherence to Improve Outcomes in Schizophrenia

Managing Transitions in Care and Adherence to Improve Outcomes in Schizophrenia

John Lauriello, MD and Diana O. Perkins, MD

Overcoming Challenges in Diagnosis and Depression Management in Pediatric Bipolar Disorder

Treating Bipolar Disorder in Pediatric Patients and Educating Patients and Parents

Melissa P. DelBello, MD, MS

Using Screening Tools and Diagnosing Bipolar Disorder in Pediatric Patients

Manpreet K. Singh, MD, MS

Current and Emerging Treatments to Address Unmet Needs in MDD

Current and Emerging Treatments to Address Unmet Needs in MDD

Michael E. Thase, MD

Getting to Remission: Differentiating Residual Symptoms From Treatment Side Effects in Major Depressive Disorder

Getting to Remission: Differentiating Residual Symptoms From Treatment Side Effects in Major Depressive Disorder

Roger S. McIntyre, MD, FRCPC

Improving the Diagnosis and Treatment of Adolescent Bipolar Disorder

Diagnosing Bipolar Disorder in Pediatric Patients

Kiki D. Chang, MD

Treating Bipolar Disorder in Adolescents

Robert L. Findling, MD, MBA

Parkinson Disease: Current Trends in Treatment and Unmet Needs

Parkinson Disease: Current and Emerging Treatment Strategies

Adolfo Ramirez-Zamora, MD

Reconsidering Insomnia as a Disorder Rather Than Just a Symptom in Psychiatric Practice

Assessing and Treating Insomnia in Patients With Psychiatric Disorders, Part 1

Ruth M. Benca, MD, PhD (Chair), and Daniel J. Buysse, MD

Assessing and Treating Insomnia in Patients With Psychiatric Disorders, Part 2

Ruth M. Benca, MD, PhD (Chair), and Daniel J. Buysse, MD

Cognitive Impairment in Patients With Depression: Awareness, Assessment, and Management

Cognitive Impairment in Major Depressive Disorder: A Case Discussion Illustrating Impact, Assessment, and Management

Larry Culpepper, MD, MPH (Chair); Raymond W. Lam, MD, FRCPC; and Roger S. McIntyre, MD, FRCPC

Strategies for Managing Patients With Depression Who Are Experiencing Cognitive Impairment

Larry Culpepper, MD, MPH

Impact of Cognitive Impairment on Functioning in Patients With Depression

Raymond W. Lam, MD, FRCPC

Available Tools for Assessing Cognitive Impairment in Major Depressive Disorder

Roger S. McIntyre, MD, FRCPC

Long-Acting Injectable Antipsychotics: Where Do They Fit in the Treatment Plan?

Long-Acting Injectable Antipsychotics: Where Do They Fit in the Treatment Plan?

Christoph U. Correll, MD, and John Lauriello, MD

What You Should Know About Tardive Dyskinesia: Screening, Causes, and New Treatment Options

Evidence-Based Strategies for Managing Tardive Dyskinesia

Joseph P. McEvoy, MD

What You Should Know About Tardive Dyskinesia: Screening, Causes, and New Treatment Options

J. Sloan Manning, MD, Joseph P. McEvoy, MD

Discussing the Risk of Tardive Dyskinesia With Patients and Screening for Signs

J. Sloan Manning, MD

Emerging Treatment Strategies for Patients With Tardive Dyskinesia

Assessing Patients for Tardive Dyskinesia

John M. Kane, MD

Comparing Treatments for Tardive Dyskinesia

Leslie L. Citrome, MD, MPH

Epidemiology and Prevention of Tardive Dyskinesia

Christoph U. Correll, MD

CME From JCPLong-acting injectable antipsychotics can be a powerful strategy in helping patients to receive ongoing benefit from treatment. You might think that you have adequately explained this treatment option to patients, but they may not understand. How can communication be improved? [top]

Optimizing Treatment Choices to Improve Adherence and Outcomes in Schizophrenia

Optimizing Treatment Choices to Improve Adherence and Outcomes in Schizophrenia

John M. Kane, MD, and Christoph U. Correll, MD

JCP CME Activities

Early Stabilization of Weight Changes Following Treatment With Olanzapine, Risperidone, and Aripiprazole: A 12-Month Naturalistic Study of First Episode Psychosis

Sally Mustafa; Ridha Joober; Srividya Iyer; Jai Shah; Martin Lepage; Ashok Malla

High Prevalence of Metabolic Syndrome Among Adolescents and Young Adults With Bipolar Disorder

Christine Li; Boris Birmaher; Brian Rooks; Mary Kay Gill; Heather Hower; David A. Axelson; Daniel P. Dickstein, MD; Tina R. Goldstein; Fangzi Liao; Shirley Yen; Jeffrey Hunt; Satish Iyengar; Neal D. Ryan; Michael A. Strober; Martin B. Keller; and Benjamin I. Goldstein

Benzodiazepine Use During Pregnancy Alone or in Combination With an Antidepressant and Congenital Malformations: Systematic Review and Meta-Analysis

Sophie Grigoriadis; Lisa Graves; Miki Peer; Lana Mamisashvili; Cindy-Lee Dennis; Simone N. Vigod; Meir Steiner; Cara Brown; Amy Cheung; Hiltrud Dawson; Neil Rector; Melanie Guenette; and Margaret Richter

Treatment of Common Mental Disorders in the United States: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III

Mark Olfson, Carlos Blanco, Melanie M. Wall, Shang-Min Liu, and Bridget F. Grant

Sex and Pubertal Status Moderate the Association Between ADHD and Depression Symptoms: An Examination from Preadolescence Through Late Adolescence

Dara E. Babinski, Daniel A. Waschbusch, and James G. Waxmonsky

Correlates of Opioid Abstinence in a 42-Month Posttreatment Naturalistic Follow-Up Study of Prescription Opioid Dependence

Roger D. Weiss, Margaret L. Griffin, David E. Marcovitz, Blake T. Hilton, Garrett M. Fitzmaurice, R. Kathryn McHugh, and Kathleen M. Carroll

Sexually Transmitted Infection Among Adolescents and Young Adults With Bipolar Disorder: A Nationwide Longitudinal Study

Mu-Hong Chen, Han-Ting Wei, Ya-Mei Bai, Kai-Lin Huang, Nai-Ying Ko, Tung-Ping Su, Cheng-Ta Li, Wei-Chen Lin, Shih-Jen Tsai, Tzeng-Ji Chen, and Ju-Wei Hsu

Efficacy and Tolerability of Pharmacotherapy for Pediatric Anxiety Disorders: A Network Meta-Analysis

Eric T. Dobson, Michael H. Bloch, and Jeffrey R. Strawn

Prevalence of and Risk Factors for Extrapyramidal Side Effects of Antipsychotics: Results From the National FACE-SZ Cohort

David Misdrahi, Arnaud Tessier, Antoine Daubigney, Wassilios G. Meissner, Franck Schurhoff, Laurent Boyer, Ophélia Godin, Ewa Bulzacka, Bruno Aouizerate, Meja Andrianarisoa, Fabrice Berna, Delphine Capdevielle, Isabelle Chereau-Boudet, Thierry D’Amato, Caroline Dubertret, Julien Dubreucq, Catherine Faget-Agius, Christophe Lançon, Jasmina Mallet, Christine Passerieux, Romain Rey, Aurélie Schandrin, Mathieu Urbach, Pierre Vidailhet, Pierre-Michel Llorca, and Guillaume Fond for the FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) Group

Blood Lithium Monitoring Practices in a Population-Based Sample of Older Adults

Soham Rej, Nathan Herrmann, Andrea Gruneir, Racquel Jandoc, Eric McArthur, Stephanie Dixon, and Amit X. Garg

A Retrospective Comparative Effectiveness Study of Medications for Posttraumatic Stress Disorder in Routine Practice

Brian Shiner, Christine Leonard Westgate, Jiang Gui, Shira Maguen, Yinong Young-Xu, Paula P. Schnurr, and Bradley V. Watts

An Examination of Screening Tools for Collaborative Care of Adolescent Depression

Alexander D. Ginsburg, Paul S. Stadem, Christopher R. Takala, Paul E. Croarkin, Angela B. Mattson, Marcie L. Billings, RoxAnne M. Brennan, and John E. Huxsahl

Trends in Illicit Drug Use Among Smokers and Nonsmokers in the United States, 2002–2014

Scott J. Moeller, PhDa; David S. Fink, MPHb; Misato Gbedemah, MPHc; Deborah S. Hasin, Sandro Galea, Michael J. Zvolensky, and Renee D. Goodwin

Managing Transitions in Care and Adherence to Improve Outcomes in Schizophrenia

Enhancing the Treatment of Patients With Schizophrenia Through Continuous Care

John Lauriello, MD, and Diana O. Perkins, MD

Improving the Diagnosis and Treatment of Adolescent Bipolar Disorder

Improving the Diagnosis and Treatment of Pediatric Bipolar Disorder

Robert L. Findling, MD, MBA (chair), and Kiki D. Chang, MD

Tardive Dyskinesia: Recognition, Patient Assessment, and Differential Diagnosis

Tardive Dyskinesia: Recognition, Patient Assessment, and Differential Diagnosis

Rakesh Jain, MD, MPH (Chair), and Christoph U. Correll, MD

Reconsidering Insomnia as a Disorder Rather Than Just a Symptom in Psychiatric Practice

Reconsidering Insomnia as a Disorder Rather Than Just a Symptom in Psychiatric Practice

Ruth M. Benca, MD, PhD, and Daniel J. Buysse, MD

Cognitive Impairment in Patients With Depression: Awareness, Assessment, and Management

Cognitive Impairment in Patients With Depression: Awareness, Assessment, and Management

Larry Culpepper, MD, MPH; Raymond W. Lam, MD, FRCPC; and Roger S. McIntyre, MD, FRCPC

Emerging Treatment Strategies for Patients With Tardive Dyskinesia

Epidemiology, Prevention, and Assessment of Tardive Dyskinesia and Advances in Treatment

Christoph U. Correll, MD (Chair), et al

Diagnosing and Treating Patients With Mixed Features

Diagnosing and Treating Patients With Mixed Features

Rakesh Jain, MD, MPH (Chair), et al

JCP SupplementAre you familiar with diagnostic criteria for Parkinson disease psychosis (PDP)? Do you know which psychotic symptoms occur in the majority of patients with PD? Read this CME supplement by 2 experts in the field for an update on PDP symptoms and treatments. [top]

Effective Management Approaches for Psychosis in Patients With Parkinson Disease

Effective Management Approaches for Psychosis in Patients With Parkinson Disease

Rajesh Pahwa, MD (Chair), and Daniel E. Kremens, MD, JD

CME From PCCCare coordination across health systems is critical to optimize patient care for chronic medical and psychiatric conditions. Group concept mapping provides a strategic process to allow shared-decision making among stakeholders. [top]

PCC CME Activities

Bridging Community Mental Health and Primary Care to Improve Medication Monitoring and Outcomes for Patients With Mental Illness Taking Second-Generation Antipsychotics (HDC/DFMC Bridge Project—Phase 1: Group Concept Mapping)

Keri Hager; Margarette Kading; Carolyn O’Donnell; Ann Yapel; Danielle MacDonald; Jennifer Nelson Albee; Cynthia Nash; Colleen Renier; Katherine Dean; and Mark Schneiderhan

Lithium Neurotoxicity Due to Second-Generation Antipsychotics Combined With Lithium: A Systematic Review

Ivan Netto, Vivek H. Phutane, and Bipin Ravindran

Posttraumatic Stress Disorder Symptoms, Functioning, and Suicidal Ideation in US Military Veterans: A Symptomics Approach

Lorig K. Kachadourian, Ilan Harpaz-Rotem, Jack Tsai, Steven M. Southwick, and Robert H. Pietrzak

Psychotropic Medication Monitoring: A Review

Matthew A. Schreiber, Stephanie C. Armstrong, and Jesse D. Markman

Stimulant Formulations for the Treatment of Attention-Deficit/Hyperactivity Disorder

Mohan Gautam and Deepak Prabhakar

Rates of Synthetic Cannabinoid Use in Adolescents Admitted to a Treatment Facility

Gloria Martz, William Tankersley, Hema Madhuri Mekala, and Huda Motiwala, MD

Posttraumatic Stress Disorder Comorbid with Mood Disorder: Significantly Higher Incidence of Obstructive Sleep Apnea Than Either Diagnosis Alone

Bettina S. Fehr, William F. Katz, Erin A. Van Enkevort, and Imran S. Khawaja

To Scan or Not to Scan: Horses and Zebras

David A. Weidman, Anna D. Burke, Jennifer M. Eschbacher, Jacquelynn N. Copeland, Michele Grigaitis-Reyes, and William J. Burke

Psychiatric and Psychological Impact of Chronic Skin Disease

Mohammad Jafferany and Paul Pastolero

Psychological Aspects of Factitious Disorder

Mohammed Jafferany, Zaira Khalid, Katherine A. McDonald, and Amanda J Shelley

Are Psychiatric Inpatients at Risk of Developing Wernicke’s Encephalopathy Being Identified and Adequately Treated?

Medhat Guirguis, Stephen Manning, Marina Chavez, Jessica Nelson, Regina Baronia, Sailatha Bobba, Jafreen Ahmed, and Ijeoma Ajufo

Efficacy of a Behavioral Activation Teletherapy Intervention to Treat Depression and Anxiety in Primary Care VitalSign6 Program

Joseph M. Trombello, Charles South, Audrey Cecil, Katherine E. Sánchez, Alma Christina Sánchez, Sara Levinson Eidelman, Taryn L. Mayes, Farra Kahalnik, Corey Tovian, Beth D. Kennard, and Madhukar H. Trivedi

Migraine Headache: Diagnosis and Current and Emerging Preventive Treatments

Migraine Headache: Diagnosis and Current and Emerging Preventive Treatments

Richard B. Lipton, MD, and Stephen Silberstein, MD

 
​​​
​​​​​​​